𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice

✍ Scribed by Lee, Eun Young; Kim, Yeon Wook; Oh, Hyunhee; Choi, Cheol Soo; Ahn, Jin Hee; Lee, Byung-Wan; Kang, Eun Seok; Cha, Bong Soo; Lee, Hyun Chul

Book ID
122159756
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
542 KB
Volume
63
Category
Article
ISSN
1532-8600

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of the subchronic antidiabeti
Comparison of the subchronic antidiabetic effects of DPP IV–resistant GIP and GLP-1 analogues in obese diabetic (ob/ob) mice
✍ Nigel Irwin; Paula L. McClean; Peter R. Flatt 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

## Abstract Glucagon‐like peptide‐1 (GLP‐1) and glucose‐dependent insulinotropic polypeptide (GIP) are the two key incretin hormones released from the gastrointestinal tract that regulate blood glucose homeostasis through potent insulin secretion. The rapid degradation of GIP and GLP‐1 by the ubiqu

Comparison of the anti-diabetic effects
Comparison of the anti-diabetic effects of GIP- and GLP-1-receptor activation in obese diabetic (ob/ob) mice: studies with DPP IV resistant N-AcGIP and exendin(1–39)amide
✍ Nigel Irwin; Paula L. McClean; Roslyn S. Cassidy; Finbarr P. M. O'Harte; Brian D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

## Abstract ## Background The two major incretin hormones, glucose‐dependent insulinotropic polypeptide (GIP) and glucagon‐like peptide‐1 (GLP‐1) are being actively explored as anti‐diabetic agents because they lower blood glucose through multiple mechanisms. The rapid inactivation of GIP and GLP‐